Learn more about our China work.
WASHINGTON – Scott Whitaker, president and CEO of AdvaMed, the Medtech Association, today called for a reciprocal “zero for zero” model with respect to tariffs among U.S. trading partners for…
Exclusive member webinar on tariffs, customs, USMCA rules of origin, and compliance strategies with expert Larry Friedman. Air Date April 4, 2025. Now On Demand!
This educational primer will break down tariffs, trade policies, and legal frameworks—giving you the basics you need to navigate upcoming changes.
Get the latest on new policy updates and guidance for the clinical evaluation of medical devices.
The AdvaMed® Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed® China Code” or “Code” – serves as a foundational charter for medical technology companies’…
The AdvaMed® Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed® China Code” or “Code” – serves as a foundational charter for medical technology companies’…
Join us for a breakdown of the Chinese medical device market, to review the current regulatory requirements and pathways, and address I.P. protection in China for U.S. companies.
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices.
AdvaMed®’s office in China sits at the forefront of helping our members navigate China’s large, fast-growing market for medical technologies.
Join us as we explore the advantages and intricacies to setting up a clinical study in China, India and Japan